Schedule 13D ownership disclosure

SATSUMA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80405P107

Event date: 2023-01-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-23-000047
Form type
SC 13D/A
Filer
Growth Equity Opportunities 17, LLC
CIK
CIK 1790256
Filed
Jan 27, 2023
Reporting period
Jan 20, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub